BioRad Recalls RPR Portion of the BioPlex 2200 Syphilis Total & RPR Test Kit

COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. 

On March 24, 2022, the CDC alerted laboratories that BioRad issued a voluntary recall for the RPR portion of the BioPlex 2200 Syphilis Total and RPR Test Kit. In response to concerns related to COVID-19 vaccine interference and false reactive RPR (Rapid Plasma Reagin; non-treponemal) results, BioRad Laboratories, Inc. has disabled the RPR portion of the Syphilis Total and RPR panels until further notice. The FDA has classified this as a Class 2 Device Recall.